US 9139834
RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis
granted A61PA61P27/00A61P27/02
Quick answer
US patent 9139834 (RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis) held by Arrowhead Research Corporation expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Research Corporation
- Grant date
- Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P27/00, A61P27/02, A61P35/00